Vor Biopharma Inc (VOR)

Jul 22, 2025

What analysts say about Vor Biopharma Inc. stockFree Bull & Bear Market Updates - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What drives Vor Biopharma Inc. stock priceFree Stock Market Beginners Guide - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Vor Biopharma Inc.'s (NASDAQ:VOR) top holders are insiders and they are likely disappointed by the recent 14% drop - Yahoo Finance

Jul 22, 2025

Jul 22, 2025

Vor Biopharma Inc. Stock Analysis and ForecastUnprecedented profits - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is Vor Biopharma Inc. a good long term investmentMarket-crushing stock picks - jammulinksnews.com

Jul 22, 2025

Jul 21, 2025

H.C. Wainwright Upgrades Vor Biopharma (VOR) to a Buy, Sets a $3 Price Target - MSN

Jul 21, 2025

Jul 21, 2025

Vor Bio Appoints Biotech Industry Leaders Alexander (Bo) Cumbo and Michel Detheux, Ph.D. to Board of Directors - Stock Titan

Jul 21, 2025

Jul 20, 2025

Vor Biopharma's Strategic Turnaround and the Case for Immediate Investment - AInvest

Jul 20, 2025

Jul 19, 2025

Vor Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - AInvest

Jul 19, 2025

Jul 18, 2025

10 Hot Penny Stocks to Invest in Now - Insider Monkey

Jul 18, 2025

Jul 18, 2025

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jul 18, 2025

Jul 18, 2025

Vor Bio Awards Massive 5.3M Share Package to New Development Chief: Full Grant Details Revealed - Stock Titan

Jul 18, 2025

Jul 18, 2025

Vor Biopharma shares rise 2.52% premarket after appointing Qing Zuraw as Chief Development Officer. - AInvest

Jul 18, 2025

Jul 18, 2025

Why Vor Biopharma Inc. stock is on top investor watchlistsFree Real-Time Market Predictions - Newser

Jul 18, 2025

Jul 17, 2025

Vor Bio Appoints Qing Zuraw, M.D. as Chief Development Officer - Yahoo Finance

Jul 17, 2025

Jul 16, 2025

Vor Biopharma Faces Crucial Market Shifts Amid Latest Developments - StocksToTrade

Jul 16, 2025

Jul 16, 2025

Vor Biopharma Stock Faces Volatile Week Amid Mixed Financial Reports - timothysykes.com

Jul 16, 2025

Jul 16, 2025

Vor Biopharma Inc. shares rise 2.00% premarket after Bonesupport CEO predicts strong growth. - AInvest

Jul 16, 2025

Jul 15, 2025

How Vor Biopharma Inc. stock performs during market volatilitySafe Entry High Exit Alerts - Newser

Jul 15, 2025

Jul 15, 2025

What makes Vor Biopharma Inc. stock price move sharplySteady Profit Stock Forecasts - Newser

Jul 15, 2025

Jul 15, 2025

Why Vor Biopharma Inc. stock attracts strong analyst attentionBreakout Confirmation Tool - newser.com

Jul 15, 2025

Jul 14, 2025

Vor Biopharma Stock’s Rollercoaster: Time to Buy?​ - StocksToTrade

Jul 14, 2025

Jul 14, 2025

VOR’s 2025 Market Dance: Up 174.66% – Time to Invest? - investchronicle.com

Jul 14, 2025

Jul 11, 2025

Vor Biopharma Explodes 22% – What’s Fueling the Surge? - AInvest

Jul 11, 2025

Jul 10, 2025

Vor Biopharma Names Sandy Mahatme as CFO, Chief Business Officer - MarketScreener

Jul 10, 2025

Jul 10, 2025

Vor Bio Appoints Veteran Biotech Executive Sandy Mahatme as Chief Financial Officer and Chief Business Officer - The Manila Times

Jul 10, 2025

Jul 10, 2025

Vor Bio Strengthens Leadership: Top Biotech Executive Who Raised $6B Joins as New CFO/CBO - Stock Titan

Jul 10, 2025

Jul 09, 2025

Vor Biopharma shares rise 5.83% intraday after $41B telitacicept licensing deal and HC Wainwright upgrade. - AInvest

Jul 09, 2025

Jul 09, 2025

Vor Biopharma Sees Unusually High Options Volume (NYSE:VOR) - Defense World

Jul 09, 2025

Jul 08, 2025

Vor Biopharma Shares Soar 23.22% on Analyst Upgrades - AInvest

Jul 08, 2025

Jul 08, 2025

Vor Biopharma: Not So Sure About This Surge, And Do Mind The Warrants - Seeking Alpha

Jul 08, 2025